Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR control number DK-1577272925-2016001331) on 18-FEB-2016. Case received from a physician via health authority on 16-FEB-2016 under reference number DK-DKMA-WBS-0002706. A 12-year-old female adolescent patient received GARDASIL, batch number unknown Dose 1 via intramuscular route on 02-OCT-2012, GARDASIL, lot/batch number unknown, Dose 2 via intramuscular route on 14-DEC-2012, GARDASIL, batch number unknown, Dose 3 via intramuscular route on 03-MAY-2013. The patient experienced Musculoskeletal pain in 2013, muscle cramps in lower leg in 2013, fever in October 2012, headache in October 2012 discontinued leisure activity taekwondo on an unknown date, limited activity level on an unknown date, pain in neck in 2013 and pain in back in 2013. 10-12 days after first dose episode with headache and fever. 1/2 year later onset of muscoskeletal symptoms with neck and back pain that limits the activity level (shorter school days, discontinued leisure activity taekwondo) accompanying headache. The patient''s outcome was reported as Not Recovered/Not Resolved except for fever and discontinued leisure activity taekwondo and limited activity level that was reported as unknown.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166